Heparan Sulfate
General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference37 reference for EP0086
| sort by year ∧ ∨ | Reference detail |
|---|---|
| 1 | Functions of heparan sulfate proteoglycans in cell signaling during development. Development. 2004 Dec ;131(24):6009-21 PMID: 15563523 |
2 | David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol. 1992 Nov ;119(4):961-75 PMID: 1385449 |
3 | Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H, David G. Differential expression of multiple cell-surface heparan sulfate proteoglycans during embryonic tooth development. J Histochem Cytochem. 1994 Aug ;42(8):1043-54 PMID: 8027524 |
4 | Kure S, Yoshie O. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1. J Immunol. 1986 Dec 15;137(12):3900-8 PMID: 2431047 |
5 | Kure S, Yoshie O, Aso H. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan. Jpn J Cancer Res. 1987 Nov ;78(11):1238-45 PMID: 2961717 |
6 | van den Born J, Gunnarsson K, Bakker MA, Kjellen L, Kusche-Gullberg M, Maccarana M, Berden JH, Lindahl U. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem. 1995 Dec 29;270(52):31303-9 PMID: 8537400 |
7 | Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight TN. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol. 1990 Nov ;137(5):1253-70 PMID: 2146882 |
8 | ten Dam GB, van de Westerlo EM, Smetsers TF, Willemse M, van Muijen GN, Merry CL, Gallagher JT, Kim YS, van Kuppevelt TH. Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n. J Biol Chem. 2004 Sep 10;279(37):38346-52 PMID: 15247295 |
9 | ten Dam GB, Hafmans T, Veerkamp JH, van Kuppevelt TH. Differential expression of heparan sulfate domains in rat spleen. J Histochem Cytochem. 2003 Jun ;51(6):727-39 PMID: 12754284 |
10 | van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem. 1998 May 22;273(21):12960-6 PMID: 9582329 |
11 | Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem. 2002 Mar 29;277(13):10982-6 PMID: 11790764 |
12 | Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, Eriksson I, Olofsson AM, Kjellen L, Forsberg E. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem. 2000 Aug 25;275(34):25926-30 PMID: 10852901 |
13 | Dempsey LA, Plummer TB, Coombes SL, Platt JL. Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology. 2000 May ;10(5):467-75 PMID: 10764835 |
14 | Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol. 1992 ;8:365-93 PMID: 1335744 |
15 | Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest. 1997 May 1;99(9):2062-70 PMID: 9151776 |
16 | Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 2003 Jul ;125(1):89-97 PMID: 12851874 |
17 | Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, Hosaka S, Beppu T, Ishiko T, Kamohara H, Ashihara H, Katagiri T, Furukawa Y, Fujiyama S, Ogawa M, Nakamura Y, Nishimura Y. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun. 2003 Jun 20;306(1):16-25 PMID: 12788060 |
18 | Hippo Y, Watanabe K, Watanabe A, Midorikawa Y, Yamamoto S, Ihara S, Tokita S, Iwanari H, Ito Y, Nakano K, Nezu J, Tsunoda H, Yoshino T, Ohizumi I, Tsuchiya M, Ohnishi S, Makuuchi M, Hamakubo T, Kodama T, Aburatani H. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res. 2004 Apr 1;64(7):2418-23 PMID: 15059894 |
19 | Veugelers M, Vermeesch J, Reekmans G, Steinfeld R, Marynen P, David G. Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Genomics. 1997 Feb 15;40(1):24-30 PMID: 9070915 |
20 | Fuxe K, Chadi G, Tinner B, Agnati LF, Pettersson R, David G. On the regional distribution of heparan sulfate proteoglycan immunoreactivity in the rat brain. Brain Res. 1994 Feb 4;636(1):131-8 PMID: 7512431 |
21 | Yokoyama H, Sato K, Okudaira M, Morita C, Takahashi C, Suzuki D, Sakai H, Iwamoto Y. Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy. Kidney Int. 1999 Aug ;56(2):650-8 PMID: 10432405 |
22 | Oshiro M, Ono K, Suzuki Y, Ota H, Katsuyama T, Mori N. Immunohistochemical localization of heparan sulfate proteoglycan in human gastrointestinal tract. Histochem Cell Biol. 2001 May ;115(5):373-80 PMID: 11449885 |
23 | van den Born J, Salmivirta K, Henttinen T, Ostman N, Ishimaru T, Miyaura S, Yoshida K, Salmivirta M. Novel heparan sulfate structures revealed by monoclonal antibodies. J Biol Chem. 2005 May 27;280(21):20516-23 PMID: 15778504 |
24 | Cheng F, Mani K, van den Born J, Ding K, Belting M, Fransson LA. Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes. J Biol Chem. 2002 Nov 15;277(46):44431-9 PMID: 12226079 |
25 | Wada M, Kato T, Kurita K, Shikama Y, Toyoshima I, Sasaki H. Detection of heparan sulfate in spinal spheroids of beta, beta'-iminodipropionitrile (IDPN)-treated rats. Neurosci Lett. 1995 Dec 29;202(1-2):137-40 PMID: 8787850 |
26 | Kamada A, Tamura I, Okazaki J, Matsukawa F, Sakaki T. Characteristics and localization of rat submandibular gland proteoglycans. Arch Oral Biol. 1996 Oct ;41(10):951-8 PMID: 9031702 |
27 | Huse B, Verca SB, Matthey P, Rusconi S. Definition of a negative modulation domain in the human progesterone receptor. Mol Endocrinol. 1998 Sep ;12(9):1334-42 PMID: 9731702 |
28 | Kato T, Kurita K, Seino T, Kadoya T, Horie H, Wada M, Kawanami T, Daimon M, Hirano A. Galectin-1 is a component of neurofilamentous lesions in sporadic and familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2001 Mar 23;282(1):166-72 PMID: 11263987 |
29 | Jenniskens GJ, Oosterhof A, Brandwijk R, Veerkamp JH, van Kuppevelt TH. Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci. 2000 Jun 1;20(11):4099-111 PMID: 10818145 |
30 | van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int. 1992 Jan ;41(1):115-23 PMID: 1593846 |
31 | Tamsma JT, van den Born J, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH, et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia. 1994 Mar ;37(3):313-20 PMID: 8174847 |
32 | van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem. 1994 Jan ;42(1):89-102 PMID: 8263327 |
33 | van Det NF, van den Born J, Tamsma JT, Verhagen NA, van den Heuvel LP, Berden JH, Bruijn JA, Daha MR, van der Woude FJ. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. Biochem J. 1995 May 1;307 ( Pt 3):759-68 PMID: 7537959 |
34 | van der Pijl JW, Daha MR, van den Born J, Verhagen NA, Lemkes HH, Bucala R, Berden JH, Zwinderman AH, Bruijn JA, van Es LA, van der Woude FJ. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane. Diabetologia. 1998 Jul ;41(7):791-8 PMID: 9686920 |
35 | Yard BA, Kahlert S, Engelleiter R, Resch S, Waldherr R, Groffen AJ, van den Heuvel LP, van der Born J, Berden JH, Kroger S, Hafner M, van der Woude FJ. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium. Exp Nephrol. 2001 ;9(3):214-22 PMID: 11340306 |
36 | Ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, Spillmann D, van Kuppevelt TH. 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem. 2006 Feb 24;281(8):4654-62 PMID: 16373349 |
37 | Stickens D, Zak BM, Rougier N, Esko JD, Werb Z. Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development. 2005 Nov ;132(22):5055-68 PMID: 16236767 |